Related Experiment Video
Updated: Jun 20, 2026

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
Renal UDP-glucuronosyltransferases and the glucuronidation of xenobiotics and endogenous mediators
Kathleen M Knights1, John O Miners
1Department of Clinical Pharmacology, Flinders University, School of Medicine, Adelaide, Australia. Kathie.knights@flinders.edu.au
Abstract:
The role of the kidney in drug and chemical disposition has traditionally focused on the excretion of polar xenobiotics and metabolites. However, there is increasing evidence demonstrating that renal UGTs are integral to the "local" intrarenal, and, possibly, systemic, metabolic clearance of numerous drugs and nondrug xenobiotics, as well as to the maintenance of renal homeostasis through limiting the biological activity of endogenous renal mediators that control electrolyte balance and renal blood flow. The common involvement of UGT1A9 and UGT2B7 in the metabolism of both endogenous and exogenous compounds in kidney predicates significant renal drug-endobiotic interactions that may explain, in part, the adverse renal effects of some drugs.
Related Concept Videos
Phase II Reactions: Glucuronidation
Drug Metabolism: Phase II Reactions
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
Drug Elimination by Renal Route: Tubular Secretion
Drug Biotransformation: Overview
